CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,847 enrolled / 1,847 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05079334
NCT05079334N/ACompletedHigh Momentum (34.2/mo)Completion was 10mo ago

Improving Identification and Healthcare for Patients With Inherited Cancer Syndromes: Evidence-based EMR Implementation Using a Web-based Computer Platform

Vanderbilt University Medical Center·observational·Posted Oct 15, 2021·Updated Jun 24, 2026

In Brief

An observational study for Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research. Completed, enrolled 1,847 participants across 2 sites.

Signals

Enrolling ahead of pace

Detailed Summary

Investigators from Vanderbilt University Medical Center (VUMC), Duke University, and Meharry Medical College (MMC) are collaborating on a family health history study to deploy a family health history (FHH) platform, MeTree. Recruited participants will complete surveys, the MeTree questionnaire, and MeTree will determine the participant's cancer risk based on current guidelines. The study team will offer genetic counseling to high-risk participants. Investigators will track participant outcomes and behaviors from the use of MeTree to determine the efficiency of the use of MeTree compared to completion of pedigrees in clinic.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 15, 2021
Enrollment StartJan 1, 2022
Primary CompletionAug 31, 2025
Study CompletionSep 1, 2025
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 4.7 years ago